- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: AMXT 1501
Total 2907 results
-
Ornovi, Inc.Withdrawn
-
Sun Pharmaceutical Industries LimitedCompletedKeratoconjunctivitis Sicca | Dry Eye DiseaseUnited States
-
Swedish Orphan BiovitrumCompletedHealthy VolunteersUnited Kingdom
-
Merck Sharp & Dohme LLCCompletedCondyloma Acuminata | Anogenital Human Papilloma Virus InfectionJapan
-
Merck Sharp & Dohme LLCCompletedCervical Cancer | Cervical Intraepithelial Neoplasia | Adenocarcinoma in Situ
-
9 Meters Biopharma, Inc.CompletedCeliac DiseaseUnited States, Canada, Spain
-
Anterios Inc.Completed
-
SensorionNot yet recruitingOtorhinolaryngologic Diseases | Ear Diseases | Hearing Disorders | Deafness | Hearing Loss, Sensorineural | Congenital Deafness | DFNB9 | OTOF Gene MutationFrance
-
Mozart Therapeutics Australia Pty LtdNot yet recruitingType 1 Diabetes | Celiac Disease | Healthy VolunteersAustralia
-
CorrectSequence Therapeutics Co., LtdRecruitingBeta-Thalassemia MajorChina
-
Children's Hospital of Fudan UniversityCorrectSequence Therapeutics Co., LtdRecruiting
-
Tvardi Therapeutics, IncorporatedRecruitingIdiopathic Pulmonary FibrosisUnited States
-
Transposon Therapeutics, Inc.RecruitingAicardi-Goutières Syndrome (AGS)United Kingdom, France, Italy
-
Wugen, Inc.RecruitingAcute Myeloid LeukemiaUnited States, Australia
-
Corat Therapeutics GmbhRecruiting
-
Canadian Cancer Trials GroupCanadian Cancer Society (CCS); ATGen Canada Inc; Ontario Institute for Cancer... and other collaboratorsActive, not recruiting
-
Neurotech PharmaceuticalsCompletedMacular Telangiectasia Type 2United States, Australia, Germany
-
Neurotech PharmaceuticalsCompletedA Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol AMacular Telangiectasia Type 2United States, United Kingdom, Australia, France
-
1ST Biotherapeutics, Inc.CompletedParkinson's DiseaseUnited States
-
Xalud Therapeutics, Inc.CompletedOsteoarthritis, KneeAustralia, United States
-
101 TherapeuticsActive, not recruitingVirus Diseases | COVID-19 | Infectious Disease | Glucocorticoids ToxicityIndia
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-type PsoriasisUnited States, Hungary, Italy, Russian Federation, Germany, Czechia, Canada
-
Sentien Biotechnologies, Inc.Active, not recruitingAcute Kidney InjuryUnited States
-
InQpharm GroupCompleted
-
Chong Kun Dang PharmaceuticalCompletedDiabetes Mellitus, Type IIKorea, Republic of
-
University Hospital, BrestUnknown
-
Chong Kun Dang PharmaceuticalCompletedLiver DysfunctionKorea, Republic of
-
InQpharm GroupCompletedConstipation | Irregular Bowel Movement FrequencyGermany
-
NorgineCompleted
-
Alaunos TherapeuticsCompletedHematologic Neoplasms | Non-Hodgkin's Lymphoma | Bone Marrow NeoplasmsUnited States
-
Cyrenaic PharmaceuticalsCompleted
-
4SC AGCompletedInflammatory Bowel Disease (IBD)Germany, Bulgaria, Romania
-
Chong Kun Dang PharmaceuticalCompleted
-
Evotec Neurosciences GmbHRichmond Pharmacology LimitedCompletedHuman VolunteersUnited Kingdom
-
Alebund PharmaceuticalsCompleted
-
BridorCompletedHealthy Obesity, MetabolicallyFrance
-
Gilead SciencesTerminatedIndolent Non-Hodgkin's LymphomasUnited States, Korea, Republic of, Hungary, United Kingdom, Australia, Singapore, Japan, Taiwan, Israel, Italy, Spain, Czechia, Russian Federation, France, Poland, Romania, Germany, Portugal, Sweden
-
Dr. August Wolff GmbH & Co. KG ArzneimittelSIT Skin Investigation and Technology Hamburg GmbHCompletedPruritus of the ScalpGermany
-
GlaxoSmithKlineCompletedNeoplasms, ProstateBelgium, France
-
Pluristem Ltd.CompletedTotal Hip Arthroplasty | Muscle InjuryGermany
-
Anbogen Therapeutics, Inc.RecruitingNon Small Cell Lung Cancer | Advanced Solid Tumor | HER2 MutationsTaiwan
-
Dyne TherapeuticsRecruitingMyotonic Dystrophy Type 1 (DM1)United Kingdom, France, Netherlands, Italy, Germany, New Zealand
-
Kanyos Bio, Inc., a wholly-owned subsidiary of...Completed
-
Xeno BiosciencesCompleted
-
Bright Minds Biosciences Pty LtdCompleted
-
Novartis Gene TherapiesCompletedSpinal Muscular Atrophy 1United States